American National Insurance’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

American National Insurance’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2,075	Closed	-$224K	–	335
2019 Q1	$224K	Buy	+2,075	New	+$207K	0.01%	318
2018 Q4	–	Sell	-2,075	Closed	-$204K	–	334
2018 Q3	$204K	Hold	2,075	–	–	0.01%	323
2018 Q2	$240K	Hold	2,075	–	–	0.01%	330
2018 Q1	$205K	Hold	2,075	–	–	0.01%	339
2017 Q4	$217K	Hold	2,075	–	–	0.01%	335
2017 Q3	$234K	Hold	2,075	–	–	0.01%	342
2017 Q2	$233K	Hold	2,075	–	–	0.01%	337
2017 Q1	$242K	Hold	2,075	–	–	0.01%	337
2016 Q4	$218K	Hold	2,075	–	–	0.01%	332
2016 Q3	$229K	Hold	2,075	–	–	0.01%	370
2016 Q2	$302K	Hold	2,075	–	–	0.02%	355
2016 Q1	$297K	Hold	2,075	–	–	0.02%	351
2015 Q4	$321K	Hold	2,075	–	–	0.02%	348
2015 Q3	$296K	Hold	2,075	–	–	0.02%	341
2015 Q2	$298K	Buy	+2,075	New	+$296K	0.02%	334

Other funds holding TARO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CAM

Claret Asset Management Montreal, Quebec, Canada $928M AUM 25.4% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

American National Insurance's TARO Position: Q2 2019 in Review

American National Insurance sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2019, closing a stake of 2,075 shares — an estimated $224K sold.

American National Insurance first reported a position in TARO in Q2 2015 and held it in 15 quarters. The position peaked at $321K in Q4 2015. 105 funds tracked by Wall St. Rank hold TARO as of Q2 2019.

American National Insurance reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2019 after selling out during the quarter.
American National Insurance sold 2,075 Taro Pharmaceutical Industries Ltd. shares in Q2 2019, an estimated $224K.
American National Insurance first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2015 and held it in 15 quarters.
American National Insurance's Taro Pharmaceutical Industries Ltd. position peaked at $321K in Q4 2015.
105 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2019.

Based on American National Insurance's 13F filing for Q2 2019, filed 5 Aug 2019.